NRX Pharmaceuticals

-$0.0373 (-6.46%) As of 3:15 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

CEO
Robert Besthof
Employees
—
Headquarters
Wilmington, Delaware
Founded
2017

NRXP Key Statistics

Market cap
35.97M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.33M
High today
$0.58
Low today
$0.511
Open price
$0.58
Volume
1.81M
52 Week high
$26.24
52 Week low
$0.4899

NRXP Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.21 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure